This is the default blog subtitle.
Please see below the latest measures taken by the EU Commission related to regulatory issues during Covid-19 Pandemic: The Commission has published guidance to ensure that clinical trials can continue taking place in the EU during the COVID-19 pandemic. The Commission welcomes the adoption by the European Parliament and the Council of the proposal to […]
Read More
As already mentioned in a previous post regarding this topic on AIR4 Renewal Programme, for the work programme, plant protection active substances have been divided into four groups based on the initial expiry date of the active substance approval and presumed characteristics of the substance: Group 1 – Substances with expiry date before 30 April […]
Read MoreAs already mentioned in a previous post regarding this topic on AIR4 Renewal Programme, for the work programme, plant protection active substances have been divided into four groups based on the initial expiry date of the active substance approval and presumed characteristics of the substance: Group 1 – Substances with expiry date before 30 April […]
Read MoreA Draft Working Document that provides an overview of indicative submission date for supplementary dossiers for the renewal of Plant Protection Active Substances whose approval expires between 1 January 2019 and 31 December 2021 was published in July 2016. The applicant must submit an application for renewal three years before the current deadline if they […]
Read More